Golexanolone affords sustained improvement of Parkinson's symptoms in rats by reducing microglia activation that restores the glutamate-GABA-dopamine pathway
作者
María A. Pedrosa,Gergana Mincheva,Mar Martinez‐García,Lola Vázquez,Thomas P. Blackburn,Magnus Doverskog,Marta Llansola,Vicente Felipo